Sufentanil Citrate
FDA-approved product (injectable, injection), marketed as Dsuvia, Sufenta Preservative Free, Sufentanil Citrate.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 2 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBL- WHO therapeutic group
- Opioid anesthetics
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against E. coli and M. tuberculosis. It was surfaced computationally for further investigation; it is not an established treatment for these infections.
AI-predicted activity
AI prediction · nothing measured- MRSA38.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli46.8% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- K. pneumoniae17.8% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis46.2% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Sufentanil Citrate with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Trimetrexate GlucuronateExisting use: Other agents against amoebiasis and other protozoal diseases88.6% AI-predicted activityagainst E. coliLab records exist17 registered studies
- Folic AcidExisting use: Acne, Anemia, Anemia (phenotype) and 8 more87.0% AI-predicted activityagainst E. coliLab records exist50+ registered studies
- MethotrexateExisting use: Acute lymphoblastic leukemia, Adenoma, Arthritis and 21 more86.8% AI-predicted activityagainst E. coliLab records exist50+ registered studies
- PralatrexateExisting use: Cancer, Mature T-cell and NK-cell non-Hodgkin lymphoma, Neoplasm and 2 more82.2% AI-predicted activityagainst E. coli44 registered studies
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives81.0% AI-predicted activityagainst E. coliLab records exist50+ registered studies
- Leucovorin CalciumExisting use: Osteosarcoma67.6% AI-predicted activityagainst E. coli50+ registered studies
- LevoleucovorinExisting use: Anemia, Colorectal adenocarcinoma, Colorectal cancer and 3 more67.6% AI-predicted activityagainst E. coli50+ registered studies
- PyrimethamineExisting use: Malaria, Toxoplasmosis64.6% AI-predicted activityagainst E. coliLab records exist50+ registered studies
- Copanlisib DihydrochlorideExisting use: Follicular lymphoma, Neoplasm, Neoplasm of mature B-cells63.5% AI-predicted activityagainst E. coli10 registered studies
- AfamelanotideExisting use: Erythropoietic protoporphyria62.6% AI-predicted activityagainst E. coli23 registered studies
- Rimegepant SulfateExisting use: Migraine disorder61.6% AI-predicted activityagainst E. coli50+ registered studies
- Histrelin AcetateExisting use: Neoplasm, Prostate adenocarcinoma, Prostate cancer61.6% AI-predicted activityagainst E. coli13 registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Evaluation of the Hemodynamic Effect of Dexmedetomidine in Scheduled Outpatient Surgery
NCT06082856 · start 2023-10-19
Registered record
- Registry ID
- NCT06082856
- Conditions
- Anesthesia; Dexmedetomidine; Hemodynamics; Ambulatory Care
- Interventions
- Dexmedetomidine; Sufentanil
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2023-10-19
- Completion
- 2026-02
- Enrolment
- 594
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnesthesia; Dexmedetomidine; Hemodynamics; Ambulatory CareInterventionDexmedetomidine; SufentanilPhaseNot applicableRegistry statusRecruitingInfluence of Nociception Level Monitor (NOL) Guided Analgesic Delivery on Robot-assisted Colorectal Surgery
NCT05662371 · start 2023-08-01
Registered record
- Registry ID
- NCT05662371
- Conditions
- Opioid Use, Unspecified; Pain, Postoperative
- Interventions
- Nociception Level monitor (NOL); Standard care
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2023-08-01
- Completion
- 2027-03-31
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOpioid Use, Unspecified; Pain, PostoperativeInterventionNociception Level monitor (NOL); Standard carePhaseNot applicableRegistry statusRecruitingEffect of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Surgery
NCT06405776 · start 2023-06-05
Registered record
- Registry ID
- NCT06405776
- Conditions
- Colorectal Cancer
- Interventions
- lidocaine; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2023-06-05
- Completion
- 2027-06-01
- Enrolment
- 276
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionColorectal CancerInterventionlidocaine; PlaceboPhaseNot applicableRegistry statusRecruitingEffect of Mild Sedation and Analgesia on Radial Artery Cannulation in Novice Residents
NCT05863455 · start 2023-05-17
Registered record
- Registry ID
- NCT05863455
- Conditions
- Sedation and Analgesia
- Interventions
- mild sedation and analgesia; control
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2023-05-17
- Completion
- 2024-10-15
- Enrolment
- 108
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSedation and AnalgesiaInterventionmild sedation and analgesia; controlPhaseNot applicableRegistry statusCompletedMini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes
NCT05718544 · start 2023-01-30
Registered record
- Registry ID
- NCT05718544
- Conditions
- Scoliosis Correction; Postoperative Analgesia; Esketamine; Dexmedetomidine; Chronic Postsurgical Pain
- Interventions
- Esketamine; Dexmedetomidine; Sufentanil
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2023-01-30
- Completion
- 2023-09-07
- Enrolment
- 199
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionScoliosis Correction; Postoperative Analgesia; Esketamine; Dexmedetomidine +1 moreInterventionEsketamine; Dexmedetomidine; SufentanilPhasePhase 4Registry statusCompletedChoice of Anesthesia in Microelectrode Recording Guided Deep Brain Stimulation for Parkinson's Disease
NCT05550714 · start 2022-10-15
Registered record
- Registry ID
- NCT05550714
- Conditions
- PD - Parkinson's Disease; Dexmedetomidine; Desflurane; Deep Brain Stimulation
- Interventions
- general anesthesia; Conscious sedation
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2022-10-15
- Completion
- 2024-09-30
- Enrolment
- 188
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPD - Parkinson's Disease; Dexmedetomidine; Desflurane; Deep Brain StimulationInterventiongeneral anesthesia; Conscious sedationPhaseNot applicableRegistry statusUnknownEvaluation of a New Pain Management Protocol Involving Intranasal Sufentanil in the Emergency Room.
NCT05498831 · start 2022-08-09
Registered record
- Registry ID
- NCT05498831
- Conditions
- Acute Pain
- Interventions
- Pain assessment at 15 minutes, 30 minutes, 60 minutes, 120 minutes after initial assessment by the triage nurse
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2022-08-09
- Completion
- 2023-02-23
- Enrolment
- 245
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAcute PainInterventionPain assessment at 15 minutes, 30 minutes, 60 minutes, 120 minutes after initial assessment by the triage nursePhaseNot recordedRegistry statusCompletedRemimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy
NCT05406102 · start 2022-07-10
Registered record
- Registry ID
- NCT05406102
- Conditions
- Anesthetics; Recovery; Drug Effect; Safety; Psychotropic Drugs; Anesthetics, Intravenous
- Interventions
- Remimazolam; Propofol group
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2022-07-10
- Completion
- 2023-06-01
- Enrolment
- 300
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnesthetics; Recovery; Drug Effect; Safety +2 moreInterventionRemimazolam; Propofol groupPhasePhase 4Registry statusUnknownNorepinephrine in Caesarian Section
NCT05264870 · start 2022-06-09
Registered record
- Registry ID
- NCT05264870
- Conditions
- Cesarean Section Complications; Hemodynamic Instability; Foetal Stress
- Interventions
- Norepinephrine; Norepinephrine
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Terminated
- Start
- 2022-06-09
- Completion
- 2025-08-27
- Enrolment
- 11
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCesarean Section Complications; Hemodynamic Instability; Foetal StressInterventionNorepinephrine; NorepinephrinePhasePhase 4Registry statusTerminatedOpioid-free Anesthesia and Thoracoscopy Surgery
NCT05308355 · start 2022-04-04
Registered record
- Registry ID
- NCT05308355
- Conditions
- Opioid Free Anesthesia; Thoracic Surgery
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2022-04-04
- Completion
- 2023-04-30
- Enrolment
- 90
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOpioid Free Anesthesia; Thoracic SurgeryInterventionNot recordedPhaseNot recordedRegistry statusCompletedDSUVIA in Patients With SCD VOC Present in the ED
NCT05388188 · start 2022-03-30
Registered record
- Registry ID
- NCT05388188
- Conditions
- Sickle-Cell Disease With Crisis
- Interventions
- sublingual sufentanil
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2022-03-30
- Completion
- 2023-12
- Enrolment
- 100
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSickle-Cell Disease With CrisisInterventionsublingual sufentanilPhaseNot recordedRegistry statusUnknownOFA in Thoracic Surgery
NCT05063396 · start 2021-10-01
Registered record
- Registry ID
- NCT05063396
- Conditions
- Thoracic Cancer
- Interventions
- opioid free anesthesia; Opioid-sparing anesthesia
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2021-10-01
- Completion
- 2025-12-01
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionThoracic CancerInterventionopioid free anesthesia; Opioid-sparing anesthesiaPhaseNot applicableRegistry statusUnknownComparison of an Opioid-Free Anesthesia Protocol Versus Standard Practices on Early and Late Post-operative Recovery
NCT04797312 · start 2021-07-12
Registered record
- Registry ID
- NCT04797312
- Conditions
- Anesthesia; Anesthesia; Adverse Effect; Opioid Analgesic Adverse Reaction; Post-Op Complication
- Interventions
- Opioid Free Anaesthesia protocol; standard practice protocol based on the use of opioids (sufentanil or remifentanil)
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2021-07-12
- Completion
- 2023-05
- Enrolment
- 140
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnesthesia; Anesthesia; Adverse Effect; Opioid Analgesic Adverse Reaction +1 moreInterventionOpioid Free Anaesthesia protocol; standard practice protocol based on the use of opioids (sufentanil or remifentanil)PhasePhase 3Registry statusUnknownImpact of Remimazolam on Prognosis After Bladder Cancer Surgery
NCT04532606 · start 2021-02-05
Registered record
- Registry ID
- NCT04532606
- Conditions
- Benzodiazepines; Bladder Cancer; Delirium; Surgery; Cancer Recurrence
- Interventions
- Remimazolam; Propofol
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Recruiting
- Start
- 2021-02-05
- Completion
- 2026-10
- Enrolment
- 1,128
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBenzodiazepines; Bladder Cancer; Delirium; Surgery +1 moreInterventionRemimazolam; PropofolPhasePhase 4Registry statusRecruitingConsistency Evaluation of the qCON, qNOX Indices and Bispectral Index
NCT04562181 · start 2020-09-30
Registered record
- Registry ID
- NCT04562181
- Conditions
- Anesthesia Monitor; Electroencephalography; Sleep
- Interventions
- Bispectral index and qCON/qNOX monitoring
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2020-09-30
- Completion
- 2021-11-05
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnesthesia Monitor; Electroencephalography; SleepInterventionBispectral index and qCON/qNOX monitoringPhaseNot applicableRegistry statusCompleted